{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:32:21Z","timestamp":1789543941442,"version":"build-2803163510"},"reference-count":275,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015471","name":"Mater Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018853","name":"Prince Charles Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ymgme.2022.106979","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T11:37:26Z","timestamp":1671449846000},"page":"106979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Fibrillin-1 and asprosin, novel players in metabolic syndrome"],"prefix":"10.1016","volume":"138","author":[{"given":"Kim M.","family":"Summers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Keshvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.106979_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ymgme.2012.07.023","article-title":"Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases","volume":"107","author":"Davis","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/iep.12239","article-title":"Fell-Muir lecture: Fibrillin microfibrils: structural tensometers of elastic tissues?","volume":"98","author":"Kielty","year":"2017","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/352334a0","article-title":"Partial sequence of a candidate gene for the Marfan syndrome","volume":"352","author":"Maslen","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/352330a0","article-title":"Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes","volume":"352","author":"Lee","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/dnares\/8.2.85","article-title":"Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro","volume":"8","author":"Nagase","year":"2001","journal-title":"DNA Res."},{"key":"10.1016\/j.ymgme.2022.106979_bb0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygeno.2003.08.023","article-title":"Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues","volume":"83","author":"Corson","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2022.106979_bb0040","first-page":"207","article-title":"Fibrillin: from microfibril assembly to biomechanical function","volume":"357","author":"Kielty","year":"2002","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0045","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1242\/jcs.115.14.2817","article-title":"Elastic fibres","volume":"115","author":"Kielty","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2015.05.002","article-title":"The fibrillin microfibril scaffold: a niche for growth factors and mechanosensation?","volume":"47","author":"Sengle","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/EBC20180052","article-title":"Recent updates on the molecular network of elastic fiber formation","volume":"63","author":"Shin","year":"2019","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0060","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0003-4975(97)00061-1","article-title":"Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan\u2019s syndrome","volume":"63","author":"Fleischer","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ymgme.2022.106979_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01241398-199905000-00002","article-title":"Changes of elastic fibers in musculoskeletal tissues of Marfan syndrome: a possible mechanism of joint laxity and skeletal overgrowth","volume":"19","author":"Gigante","year":"1999","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.ymgme.2022.106979_bb0070","article-title":"Zinn's zonule","author":"Bassnett","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymgme.2022.106979_bb0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/ng1295-456","article-title":"Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly","volume":"11","author":"Putnam","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0945-053X(98)90106-8","article-title":"Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins","volume":"17","author":"Sinha","year":"1998","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0085","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0008-6363(01)00512-0","article-title":"Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury","volume":"53","author":"Sinha","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymgme.2022.106979_bb0090","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","article-title":"Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein","volume":"278","author":"Isogai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.matbio.2006.12.006","article-title":"LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein","volume":"26","author":"Hirani","year":"2007","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.c.30068","article-title":"Recent progress towards a molecular understanding of Marfan syndrome","volume":"139C","author":"Dietz","year":"2005","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0110","doi-asserted-by":"crossref","first-page":"13874","DOI":"10.1074\/jbc.M707820200","article-title":"Targeting of bone morphogenetic protein growth factor complexes to fibrillin","volume":"283","author":"Sengle","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0115","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1093\/hmg\/ddq409","article-title":"Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome","volume":"19","author":"Nistala","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0120","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.201003089","article-title":"Fibrillin-1 and -2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation","volume":"190","author":"Nistala","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0125","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1242\/jcs.127571","article-title":"Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism","volume":"126","author":"Tiedemann","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.genom.8.080706.092303","article-title":"Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction","volume":"9","author":"Milewicz","year":"2008","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0135","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","article-title":"Dimorphic effects of transforming growth factor-beta signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome","volume":"35","author":"Cook","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0140","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/ATVBAHA.117.309401","article-title":"TGF-beta (transforming growth factor-beta) signaling protects the thoracic and abdominal aorta from angiotensin II-induced pathology by distinct mechanisms","volume":"37","author":"Angelov","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a fasting-induced glucogenic protein hormone","volume":"165","author":"Romere","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2022.106979_bb0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cmet.2019.05.022","article-title":"OLFR734 mediates glucose metabolism as a receptor of asprosin","volume":"30","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0155","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nm.4432","article-title":"Asprosin is a centrally acting orexigenic hormone","volume":"23","author":"Duerrschmid","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2022.02.012","article-title":"Protein tyrosine phosphatase receptor delta serves as the orexigenic asprosin receptor","volume":"34","author":"Mishra","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0165","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2022.106979_bb0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymgme.2022.106979_bb0175","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63784","article-title":"Asprosin-neutralizing antibodies as a treatment for metabolic syndrome","volume":"10","author":"Mishra","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymgme.2022.106979_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2020.00064","article-title":"Asprosin: a novel player in metabolic diseases","volume":"11","author":"Yuan","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0190","article-title":"Asprosin and type 2 diabetes mellitus: a novel potential therapeutic implication","volume":"34","author":"Bhadel","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.ymgme.2022.106979_bb0195","doi-asserted-by":"crossref","DOI":"10.1097\/j.pbj.0000000000000108","article-title":"A state of the art review on the novel mediator asprosin in the metabolic syndrome","volume":"5","author":"Luis","year":"2020","journal-title":"Porto Biomed. J."},{"key":"10.1016\/j.ymgme.2022.106979_bb0200","series-title":"Health and Disease Molecular Syndromology","first-page":"175","article-title":"Asprosin, a C-terminal cleavage product of fibrillin 1 encoded by the FBN1 gene","volume":"13","author":"Ovali","year":"2022"},{"key":"10.1016\/j.ymgme.2022.106979_bb0205","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.2147\/DMSO.S376163","article-title":"New discovered adipokines associated with the pathogenesis of obesity and type 2 diabetes diabetes","volume":"15","author":"Cheng","year":"2022","journal-title":"Metab. Syndr. Obes."},{"key":"10.1016\/j.ymgme.2022.106979_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12967-022-03542-0","article-title":"Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38\/Elk-1 pathway","volume":"20","author":"Zou","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/JOE-20-0503","article-title":"Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue","volume":"249","author":"Miao","year":"2021","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0220","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","article-title":"Asprosin impairs insulin secretion in response to glucose and viability through TLR4\/JNK-mediated inflammation","volume":"486","author":"Lee","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0225","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1002\/jcp.28694","article-title":"Asprosin attenuates insulin signaling pathway through PKC\u03b4-activated ER stress and inflammation in skeletal muscle","volume":"234","author":"Jung","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jcp.29835","article-title":"Asprosin promotes \u03b2-cell apoptosis by inhibiting the autophagy of \u03b2-cell via AMPK-mTOR pathway","volume":"236","author":"Wang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12933-022-01457-0","article-title":"Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease","volume":"21","author":"You","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0240","article-title":"Discovery of a possible role of asprosin in ovarian follicular function","author":"Maylem","year":"2020","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.theriogenology.2021.11.004","article-title":"A potential role of fibrillin-1 (FBN1) mRNA and asprosin in follicular development in water buffalo","volume":"178","author":"Maylem","year":"2022","journal-title":"Theriogenology"},{"key":"10.1016\/j.ymgme.2022.106979_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195942","article-title":"Differential regulation of genes by the glucogenic hormone asprosin in ovarian cancer","volume":"11","author":"Kerslake","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2020.109737","article-title":"Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK","volume":"144","author":"Zhang","year":"2021","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0260","doi-asserted-by":"crossref","first-page":"2521096","DOI":"10.1155\/2019\/2521096","article-title":"Saliva and blood asprosin hormone concentration associated with obesity","volume":"2019","author":"Ugur","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0265","doi-asserted-by":"crossref","DOI":"10.5603\/EP.a2020.0017","article-title":"Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin","author":"Gozel","year":"2020","journal-title":"Endokrynologia Polska"},{"key":"10.1016\/j.ymgme.2022.106979_bb0270","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/s41598-022-05060-x","article-title":"Sensitive asprosin detection in clinical samples reveals serum\/saliva correlation and indicates cartilage as source for serum asprosin","volume":"12","author":"Morcos","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2022.106979_bb0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/jmbi.1996.0003","article-title":"Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1","volume":"255","author":"Knott","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0280","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1073\/pnas.1401697111","article-title":"C-terminal propeptide is required for fibrillin-1 secretion and blocks premature assembly through linkage to domains cbEGF41\u201343","volume":"111","author":"Jensen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2022.106979_bb0285","doi-asserted-by":"crossref","first-page":"36035","DOI":"10.1074\/jbc.M104985200","article-title":"Interactions of fibrillin-1 with heparin\/heparan sulfate, implications for microfibrillar assembly","volume":"276","author":"Tiedemann","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0290","doi-asserted-by":"crossref","first-page":"30526","DOI":"10.1074\/jbc.M501390200","article-title":"Fibrillin-1 interactions with heparin. Implications for microfibril and elastic fiber assembly","volume":"280","author":"Cain","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0295","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.str.2013.08.004","article-title":"Structure of the fibrillin-1 N-terminal domains suggests that heparan sulfate regulates the early stages of microfibril assembly","volume":"21","author":"Yadin","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ymgme.2022.106979_bb0300","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.febslet.2014.06.061","article-title":"Heparin\/heparan sulfate controls fibrillin-1, \u22122 and \u22123 self-interactions in microfibril assembly","volume":"588","author":"Sabatier","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2022.106979_bb0305","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/jmbi.1996.0237","article-title":"Fibrillin-1: organization in microfibrils and structural properties","volume":"258","author":"Reinhardt","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"Pt 7","key":"10.1016\/j.ymgme.2022.106979_bb0310","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1242\/jcs.112.7.1093","article-title":"Carboxy-terminal conversion of profibrillin to fibrillin at a basic site by PACE\/furin-like activity required for incorporation in the matrix","volume":"112","author":"Raghunath","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pmic.200401340","article-title":"Proteomic analysis of fibrillin-rich microfibrils","volume":"6","author":"Cain","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.ymgme.2022.106979_bb0320","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/7.13.2039","article-title":"Evidence for furin-type activity-mediated C-terminal processing of profibrillin-1 and interference in the processing by certain mutations","volume":"7","author":"Lonnqvist","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0325","doi-asserted-by":"crossref","first-page":"16094","DOI":"10.1016\/S0021-9258(18)41971-0","article-title":"Purification and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells","volume":"267","author":"Hatsuzawa","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0330","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen","volume":"267","author":"Molloy","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0335","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","article-title":"Gateways to the FANTOM5 promoter level mammalian expression atlas","volume":"16","author":"Lizio","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0340","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00429896","article-title":"Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes","volume":"14","author":"van de Ven","year":"1990","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ymgme.2022.106979_bb0345","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/j.1460-2075.1994.tb06231.x","article-title":"Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface","volume":"13","author":"Molloy","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2022.106979_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1172\/JCI115589","article-title":"Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts","volume":"89","author":"Milewicz","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.106979_bb0355","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jcb.10657","article-title":"Profibrillin-1 maturation by human dermal fibroblasts: proteolytic processing and molecular chaperones","volume":"90","author":"Wallis","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0360","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1074\/jbc.274.13.8933","article-title":"Processing of the fibrillin-1 carboxyl-terminal domain","volume":"274","author":"Ritty","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semcdb.2018.07.016","article-title":"Fibrillin microfibrils and elastic fibre proteins: functional interactions and extracellular regulation of growth factors","volume":"89","author":"Thomson","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0370","doi-asserted-by":"crossref","first-page":"50795","DOI":"10.1074\/jbc.M210611200","article-title":"Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils","volume":"277","author":"Lin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0375","doi-asserted-by":"crossref","first-page":"16872","DOI":"10.1074\/jbc.M809348200","volume":"284","author":"Ono","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0380","doi-asserted-by":"crossref","first-page":"35044","DOI":"10.1074\/jbc.M206363200","article-title":"Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly","volume":"277","author":"Penner","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0385","doi-asserted-by":"crossref","first-page":"39661","DOI":"10.1074\/jbc.M104533200","article-title":"Protein interaction studies of MAGP-1 with tropoelastin and fibrillin-1","volume":"276","author":"Jensen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0390","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1091\/mbc.e08-08-0830","article-title":"Fibrillin assembly requires fibronectin","volume":"20","author":"Sabatier","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymgme.2022.106979_bb0395","article-title":"Elastic fibre proteins in Elastogenesis and wound healing","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0400","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0405","doi-asserted-by":"crossref","first-page":"14763","DOI":"10.1016\/S0021-9258(18)98752-1","article-title":"Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils","volume":"266","author":"Sakai","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0410","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.med.51.1.481","article-title":"The Marfan syndrome","volume":"51","author":"Pyeritz","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0415","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41436-018-0399-4","article-title":"Marfan syndrome: improved clinical history results in expanded natural history","volume":"21","author":"Pyeritz","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0420","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0425","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.10249","article-title":"Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database","volume":"22","author":"Collod-Beroud","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2022.106979_bb0430","series-title":"The UMD-FBN1 mutations database","author":"Collod-Beroud","year":"2014"},{"key":"10.1016\/j.ymgme.2022.106979_bb0435","first-page":"361","article-title":"Arachnodactyly (Dystrophia Mesodermalis Congenita, Typus Marfans. Marfan\u2019s syndrome. Dolichostenomelie)","volume":"32","author":"Lloyd","year":"1934","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.ymgme.2022.106979_bb0440","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ajmg.a.30981","article-title":"Histopathology and fibrillin-1 distribution in severe early onset Marfan syndrome","volume":"139","author":"Summers","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2022.106979_bb0445","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/341581","article-title":"Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes","volume":"71","author":"Schrijver","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0450","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/302582","article-title":"Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes","volume":"65","author":"Schrijver","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0455","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002185","article-title":"Looking for the missing links: challenges in the search for genotype-phenotype correlation in Marfan syndrome","volume":"11","author":"De Backer","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0460","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1172\/JCI117298","article-title":"Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms","volume":"94","author":"Aoyama","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.106979_bb0465","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/ajmg.a.33690","article-title":"Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3\u2032 terminus of the FBN1-gene","volume":"152A","author":"Graul-Neumann","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2022.106979_bb0470","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ajmg.a.33906","article-title":"Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3\u2032 end of the FBN1 gene","volume":"155A","author":"Goldblatt","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2022.106979_bb0475","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajmg.a.33905","article-title":"Progeroid facial features and lipodystrophy associated with a novel splice site mutation in the final intron of the FBN1 gene","volume":"155A","author":"Horn","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2022.106979_bb0480","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/ajmg.a.36157","article-title":"Severe congenital lipodystrophy and a progeroid appearance: mutation in the penultimate exon of FBN1 causing a recognizable phenotype","volume":"161A","author":"Takenouchi","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2022.106979_bb0485","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmg.2014.02.012","article-title":"Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3\u2032 end of FBN1 gene","volume":"57","author":"Jacquinet","year":"2014","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0490","doi-asserted-by":"crossref","unstructured":"M. Lin, Z. Liu, G. Liu, S. Zhao, C. Li, W. Chen, Z. Coban Akdemir, J. Lin, X. Song, S. Wang, Q. Xu, Y. Zhao, L. Wang, Y. Zhang, Z. Yan, S. Liu, J. Liu, Y. Chen, Y. Zuo, X. Yang, T. Sun, X.Z. Yang, Y. Niu, X. Li, W. You, B. Qiu, C. Ding, P. Liu, S. Zhang, C.M.B. Carvalho, J.E. Posey, G. Qiu, J.R. Lupski, Z. Wu, J. Zhang, N. Wu, Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1 Mol. Genet. Genom. Med. 8 (2020) e1023,https:\/\/doi.org\/10.1002\/mgg3.1023.","DOI":"10.1002\/mgg3.1023"},{"key":"10.1016\/j.ymgme.2022.106979_bb0495","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1172\/JCI117930","article-title":"A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome","volume":"95","author":"Milewicz","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.106979_bb0500","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/humu.9377","article-title":"Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies","volume":"26","author":"Arbustini","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2022.106979_bb0505","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/humu.9505","article-title":"The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations","volume":"28","author":"Comeglio","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2022.106979_bb0510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1399-0004.2008.01007.x","article-title":"FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations","volume":"74","author":"Attanasio","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0515","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ejhg.2009.36","article-title":"Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene","volume":"17","author":"Stheneur","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmg.2008.11.004","article-title":"Compound-heterozygous Marfan syndrome","volume":"52","author":"Van Dijk","year":"2009","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0525","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cge.12094","article-title":"Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability","volume":"84","author":"Callier","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0530","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2350-15-23","article-title":"Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome","volume":"15","author":"Pepe","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0535","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jmg.39.8.589","article-title":"Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice","volume":"39","author":"Halliday","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0540","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12079-020-00566-3","article-title":"Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders","volume":"14","author":"Muthu","year":"2020","journal-title":"J. Cell Comm. Signal."},{"key":"10.1016\/j.ymgme.2022.106979_bb0545","first-page":"137","article-title":"The prevalence and clinical impact of obesity in adults with Marfan syndrome","volume":"26","author":"Yetman","year":"2010","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0550","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/rheumatology\/kel450","article-title":"Muscle strength and body composition in adult women with Marfan syndrome","volume":"46","author":"Percheron","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2022.106979_bb0555","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s10038-020-00843-4","article-title":"GWA-based pleiotropic analysis identified potential SNPs and genes related to type 2 diabetes and obesity","volume":"66","author":"Zeng","year":"2021","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0560","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003500","article-title":"Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits","volume":"9","author":"Randall","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0570","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng.685","article-title":"Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution","volume":"42","author":"Heid","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0575","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.matbio.2016.02.006","article-title":"Characterization of metabolic health in mouse models of fibrillin-1 perturbation","volume":"55","author":"Walji","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0580","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.matbio.2022.05.002","article-title":"Fibrillin-1 regulates white adipose tissue development, homeostasis, and function","volume":"110","author":"Muthu","year":"2022","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0585","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2016.06.009","article-title":"Expression of FBN1 during adipogenesis: relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions","volume":"119","author":"Davis","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0590","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41436-021-01132-x","article-title":"Clinical relevance of genotype-phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants","volume":"23","author":"Arnaud","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb0595","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddg081","article-title":"Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders","volume":"12","author":"Whiteman","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0600","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.106979_bb0605","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-007-0371-x","article-title":"Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome","volume":"122","author":"Matyas","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0610","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1093\/hmg\/ddv181","article-title":"A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias","volume":"24","author":"Jensen","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0615","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in marfan syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010438","article-title":"Multi-omics profiling in marfan syndrome: further insights into the molecular mechanisms involved in aortic disease","volume":"23","author":"Verhagen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0625","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature13182","article-title":"A promoter-level mammalian expression atlas","volume":"507","author":"Forrest","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0630","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2009-10-7-r79","article-title":"Methods for analyzing deep sequencing expression data: constructing the human and mouse promoterome with deepCAGE data","volume":"10","author":"Balwierz","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006997","article-title":"A high resolution atlas of gene expression in the domestic sheep (Ovis aries)","volume":"13","author":"Clark","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0640","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3389\/fgene.2020.00919","article-title":"Expression of calcification and extracellular matrix genes in the cardiovascular system of the healthy domestic sheep (Ovis aries)","volume":"11","author":"Tsang","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0645","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3389\/fgene.2019.01355","article-title":"Functional annotation of the transcriptome of the pig, Sus scrofa, based upon network analysis of an RNAseq transcriptional atlas","volume":"10","author":"Summers","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb0650","article-title":"Generation and network analysis of an RNA-seq transcriptional atlas for the rat","volume":"4","author":"Summers","year":"2022","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.ymgme.2022.106979_bb0655","doi-asserted-by":"crossref","first-page":"9471583","DOI":"10.1155\/2018\/9471583","article-title":"Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion","volume":"2018","author":"Wang","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ymgme.2022.106979_bb0660","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","article-title":"Serum asprosin levels and bariatric surgery outcomes in obese adults","volume":"43","author":"Wang","year":"2019","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ymgme.2022.106979_bb0665","article-title":"Asprosin is associated with anorexia and body fat mass in cancer patients supportive care in cancer\u202f: official journal of the multinational association of","author":"Du","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ymgme.2022.106979_bb0670","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1369\/0022155415580622","article-title":"Correlation between Fibrillin-1 degradation and mRNA downregulation and Myofibroblast differentiation in cultured human dental pulp tissue","volume":"63","author":"Yoshiba","year":"2015","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0675","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nature06902","article-title":"Dynamics of fat cell turnover in humans","volume":"453","author":"Spalding","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0680","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1080\/07420528.2020.1792482","article-title":"Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight\/obese versus normal weight adult men","volume":"37","author":"Ceylan","year":"2020","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.ymgme.2022.106979_bb0685","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","article-title":"Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris","volume":"562","author":"The Tabula Muris Consortium","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2022.106979_bb0690","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1189\/jlb.1A0417-150RR","article-title":"Identification of the macrophage-specific promoter signature in FANTOM5 mouse embryo developmental time course data","volume":"102","author":"Summers","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2022.106979_bb0695","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj3400171","article-title":"Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling","volume":"340","author":"Ashworth","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2022.106979_bb0700","doi-asserted-by":"crossref","first-page":"20242","DOI":"10.1074\/jbc.M109.087031","article-title":"Microfibril structure masks fibrillin-2 in postnatal tissues","volume":"285","author":"Charbonneau","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0705","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/1523-1747.ep12339373","article-title":"Fibrillin and elastin expression in skin regenerating from cultured keratinocyte autografts: morphogenesis of microfibrils begins at the dermo-epidermal junction and precedes elastic fiber formation","volume":"106","author":"Raghunath","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0710","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mehy.2018.07.008","article-title":"Asprosin: possible target in connection with ghrelin and cytokine network expression in the post-burn treatment","volume":"118","author":"Donma","year":"2018","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ymgme.2022.106979_bb0715","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00018-003-3273-7","article-title":"Olfactory receptors","volume":"61","author":"Gaillard","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0720","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1073\/pnas.0803229106","article-title":"Positive Darwinian selection and the birth of an olfactory receptor clade in teleosts","volume":"106","author":"Hussain","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2022.106979_bb0725","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41421-019-0122-x","article-title":"The Asprosin-OLFR734 hormonal signaling axis modulates male fertility","volume":"5","author":"Wei","year":"2019","journal-title":"Cell Discov."},{"key":"10.1016\/j.ymgme.2022.106979_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygcen.2022.114036","article-title":"Asprosin modulates testicular functions during ageing in mice","volume":"323-324","author":"Maurya","year":"2022","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0735","doi-asserted-by":"crossref","DOI":"10.1111\/and.14579","article-title":"Asprosin promotes steroidogenesis and spermatogenesis with improved glucose metabolism in adult mice testis","author":"Maurya","year":"2022","journal-title":"Andrologia"},{"key":"10.1016\/j.ymgme.2022.106979_bb0740","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.231","article-title":"Oocyte-specific deletion of furin leads to female infertility by causing early secondary follicle arrest in mice","volume":"8","author":"Meng","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymgme.2022.106979_bb0745","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09800","article-title":"Cell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to weight-loss","volume":"4","author":"Henry","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.ymgme.2022.106979_bb0750","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/emboj\/19.12.2775","article-title":"Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice","volume":"19","author":"Uetani","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2022.106979_bb0755","article-title":"The effects of asprosin on exercise-intervention in metabolic diseases","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0760","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/geno.1993.1350","article-title":"Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5\u2032 end","volume":"17","author":"Corson","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2022.106979_bb0765","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.biocel.2007.09.004","article-title":"A short ultraconserved sequence drives transcription from an alternate FBN1 promoter","volume":"40","author":"Guo","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0770","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygeno.2009.06.005","article-title":"Experimental and bioinformatic characterisation of the promoter region of the Marfan syndrome gene, FBN1","volume":"94","author":"Summers","year":"2009","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2022.106979_bb0775","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0022-2836(83)80341-6","article-title":"A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides","volume":"167","author":"Perlman","year":"1983","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0780","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-2836(85)90046-4","article-title":"Signal sequences. The limits of variation","volume":"184","author":"von Heijne","year":"1985","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0785","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejcb.2018.06.003","article-title":"A comprehensive review of signal peptides: structure, roles, and applications","volume":"97","author":"Owji","year":"2018","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0790","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.cellbio.24.110707.175320","article-title":"Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells","volume":"24","author":"Nickel","year":"2008","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0795","series-title":"Endotext [Internet]","article-title":"Insulin biosynthesis, secretion, structure, and structure-activity relationships","author":"Weiss","year":"2014"},{"key":"10.1016\/j.ymgme.2022.106979_bb0800","series-title":"Translational Biology in Medicine","author":"Montano","year":"2015"},{"key":"10.1016\/j.ymgme.2022.106979_bb0805","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.matbio.2010.10.003","article-title":"Fibrillin-3 expression in human development","volume":"30","author":"Sabatier","year":"2011","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0810","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949530","article-title":"Placensin is a glucogenic hormone secreted by human placenta","volume":"21","author":"Yu","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymgme.2022.106979_bb0815","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0002-9378(91)90012-G","article-title":"Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women","volume":"165","author":"Catalano","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0820","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2018.01.050","article-title":"A spotlight on appetite","volume":"97","author":"Beutler","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ymgme.2022.106979_bb0825","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2337\/dbi19-0009","article-title":"Energy regulation mechanism and therapeutic potential of asprosin","volume":"69","author":"Hoffmann","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2022.106979_bb0830","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40348-020-00110-8","article-title":"Asprosin in pregnancy and childhood","volume":"7","author":"Janoschek","year":"2020","journal-title":"Mol. Cell Pediatr."},{"key":"10.1016\/j.ymgme.2022.106979_bb0835","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cytogfr.2021.05.002","article-title":"Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: comprehensive review of preclinical and clinical evidence","volume":"60","author":"Shabir","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymgme.2022.106979_bb0840","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2019.02.004","article-title":"Case reports of pre-clinical replication studies in metabolism and diabetes","volume":"29","author":"von Herrath","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101762","article-title":"Overexpression and ELISA-based detection of asprosin in cultured cells and mice","volume":"3","author":"Mishra","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ymgme.2022.106979_bb0850","doi-asserted-by":"crossref","first-page":"777129","DOI":"10.3389\/fpubh.2022.777129","article-title":"Ameliorative effect of oxytocin on FBN1 and PEPCK gene expression, and behavioral patterns in rats' obesity-induced diabetes","volume":"10","author":"Elnagar","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ymgme.2022.106979_bb0855","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.tem.2021.09.005","article-title":"Caudamins, a new subclass of protein hormones","volume":"32","author":"Basu","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0860","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/emboj\/19.6.1187","article-title":"Secreted cathepsin L generates endostatin from collagen XVIII","volume":"19","author":"Felbor","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2022.106979_bb0865","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1172\/JCI63930","article-title":"Adipocyte-derived endotrophin promotes malignant tumor progression","volume":"122","author":"Park","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.106979_bb0870","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1074\/jbc.M210445200","article-title":"Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan","volume":"278","author":"Mongiat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0875","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","article-title":"Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth","volume":"275","author":"Kamphaus","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0880","doi-asserted-by":"crossref","first-page":"21340","DOI":"10.1074\/jbc.M001956200","article-title":"Distinct antitumor properties of a type IV collagen domain derived from basement membrane","volume":"275","author":"Maeshima","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0885","first-page":"1","article-title":"An investigation of the relationship between new fasting hormone asprosin, obesity and acute-chronic exercise: current systematic review","author":"Ceylan","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ymgme.2022.106979_bb0890","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/ped.14176","article-title":"Increased serum circulating asprosin levels in children with obesity","volume":"62","author":"Silistre","year":"2020","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgme.2022.106979_bb0895","doi-asserted-by":"crossref","first-page":"6622129","DOI":"10.1155\/2021\/6622129","article-title":"High serum asprosin levels are associated with presence of metabolic syndrome","volume":"2021","author":"Hong","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0900","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0069","article-title":"Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy","volume":"11","author":"Hoffmann","year":"2022","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.ymgme.2022.106979_bb0905","article-title":"A cross-sectional comparative study on the effects of body mass index and exercise\/sedentary on serum asprosin in male college students","volume":"17","author":"Huang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2022.106979_bb0910","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.896735","article-title":"Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic- pituitary-gonad-axis dysfunction in obese men","volume":"13","author":"Yao","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb0915","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000503808","article-title":"Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity","volume":"75","author":"Wang","year":"2019","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0920","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40519-020-00845-3","article-title":"Increased plasma asprosin levels in patients with drug-naive anorexia nervosa","volume":"26","author":"Hu","year":"2020","journal-title":"Eating Weight Disord."},{"key":"10.1016\/j.ymgme.2022.106979_bb0925","doi-asserted-by":"crossref","DOI":"10.1007\/s40519-022-01431-5","article-title":"Increased plasma asprosin levels are associated with overeating and loss of control in drug-free bulimia nervosa","author":"Hu","year":"2022","journal-title":"Eating Weight Disord."},{"key":"10.1016\/j.ymgme.2022.106979_bb0930","doi-asserted-by":"crossref","first-page":"101397","DOI":"10.1016\/j.tice.2020.101397","article-title":"Expression of asprosin in rat hepatic, renal, heart, gastric, testicular and brain tissues and its changes in a streptozotocin-induced diabetes mellitus model","volume":"66","author":"Kocaman","year":"2020","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ymgme.2022.106979_bb0935","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","article-title":"Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride","volume":"489","author":"Zhang","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2022.106979_bb0940","doi-asserted-by":"crossref","first-page":"7375294","DOI":"10.1155\/2018\/7375294","article-title":"Plasma Asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases","volume":"2018","author":"Li","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ymgme.2022.106979_bb0945","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jdi.13148","article-title":"Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.ymgme.2022.106979_bb0950","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13098-020-00564-w","article-title":"Serum concentration of asprosin in new-onset type 2 diabetes","volume":"12","author":"Naiemian","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"issue":"2021","key":"10.1016\/j.ymgme.2022.106979_bb0955","first-page":"590","article-title":"Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study","volume":"67","author":"Jiang","year":"1992","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.ymgme.2022.106979_bb0960","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13098-021-00652-5","article-title":"Effect of sodium-glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus","volume":"13","author":"Jiang","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ymgme.2022.106979_bb0965","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2021.211015","article-title":"Two important players for type 2 diabetes mellitus: Metrnl and Asprosin","volume":"68","author":"Timurkaan","year":"2022","journal-title":"Clin. Lab."},{"key":"10.1016\/j.ymgme.2022.106979_bb0970","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031334","article-title":"Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight\/obesity patients with type 2 diabetes mellitus","volume":"101","author":"Dai","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2022.106979_bb0975","doi-asserted-by":"crossref","first-page":"170132","DOI":"10.1016\/j.peptides.2019.170132","article-title":"Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus","volume":"120","author":"Baykus","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.ymgme.2022.106979_bb0980","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2020.02.004","article-title":"Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: a nested case-control study","volume":"93","author":"Zhong","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.ymgme.2022.106979_bb0985","first-page":"54","article-title":"Plasma asprosin levels changes in pregnant and non-pregnant rats with and without gestational diabetes","volume":"9","author":"Rezk","year":"2020","journal-title":"Int. J. Med. Res. Health Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb0990","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1097\/IAE.0000000000002776","article-title":"Altered blood and aqueous humor levels of asprosin, 4-hydroxynonenal, and 8-hydroxy-deoxyguanosine in patients with diabetes mellitus and cataract with and without diabetic retinopathy","volume":"40","author":"Oruc","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.ymgme.2022.106979_bb0995","first-page":"2117","article-title":"The relationship of serum asprosin level with diabetic and non-diabetic retinopathy","volume":"26","author":"Atli","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb1000","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.2147\/DMSO.S283413","article-title":"Higher serum asprosin level is associated with urinary albumin excretion and renal function in type 2 diabetes","volume":"13","author":"Deng","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ymgme.2022.106979_bb1005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13098-021-00668-x","article-title":"Increased serum asprosin is correlated with diabetic nephropathy","volume":"13","author":"Wang","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ymgme.2022.106979_bb1010","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1007\/s11033-021-06551-2","article-title":"Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy","volume":"48","author":"Goodarzi","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ymgme.2022.106979_bb1015","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2147\/DMSO.S361808","article-title":"Association between serum Asprosin and diabetic nephropathy in patients with type 2 diabetes mellitus in the community: a cross-sectional study","volume":"15","author":"Xu","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ymgme.2022.106979_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2022.04.018","article-title":"Association between circulating asprosin levels and carotid atherosclerotic plaque in patients with type 2 diabetes","author":"Deng","year":"2022","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2022.106979_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155184","article-title":"Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease","volume":"134","author":"Ke","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.ymgme.2022.106979_bb1030","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12519-021-00444-x","article-title":"Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity","volume":"17","author":"Liu","year":"2021","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.106979_bb1035","doi-asserted-by":"crossref","DOI":"10.1007\/s11325-021-02298-z","article-title":"Association of serum asprosin concentrations with obstructive sleep apnea syndrome","author":"Ding","year":"2021","journal-title":"Sleep Breath."},{"key":"10.1016\/j.ymgme.2022.106979_bb1040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/09513590.2018.1512967","article-title":"Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome","volume":"35","author":"Alan","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1045","first-page":"1","article-title":"Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis","author":"Perez-Lopez","year":"2022","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1050","first-page":"1039","article-title":"The role of novel hormone asprosin in insulin resistance during preeclampsia","volume":"34","author":"Shafi","year":"2021","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb1055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112382","article-title":"Prenatal screening of trisomy 21: could oxidative stress markers play a role?","volume":"10","author":"Buczynska","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb1060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/nbu.12542","article-title":"Association of maternal and umbilical cord blood asprosin with excessive gestational weight gain","volume":"47","author":"Behrasi","year":"2022","journal-title":"Nutr. Bull."},{"key":"10.1016\/j.ymgme.2022.106979_bb1065","doi-asserted-by":"crossref","DOI":"10.21470\/1678-9741-2021-0003","article-title":"Evaluation of plasma asprosin concentration in patients with coronary artery disease","author":"Guven","year":"2022","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"10.1016\/j.ymgme.2022.106979_bb1070","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2017.12.032","article-title":"A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin","volume":"36","author":"Acara","year":"2018","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb1075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12872-020-01680-1","article-title":"The role of Asprosin in patients with dilated cardiomyopathy","volume":"20","author":"Wen","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ymgme.2022.106979_bb1080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12944-021-01514-9","article-title":"Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study","volume":"20","author":"Moradi","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ymgme.2022.106979_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101855","article-title":"Asprosin and meteorin-like protein immunoreactivity in invasive ductal breast carcinoma stages","volume":"77","author":"Akkus","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ymgme.2022.106979_bb1090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10520295.2019.1656344","article-title":"Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?","volume":"95","author":"Kocaman","year":"2020","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.ymgme.2022.106979_bb1095","article-title":"A serum marker for early pancreatic cancer with a possible link to diabetes","author":"Nam","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ymgme.2022.106979_bb1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101752","article-title":"Two Novel Biomarker Candidates for Differentiating Basal Cell Carcinoma from Trichoblastoma; Asprosin and Meteorine Like Peptide","volume":"76","author":"Kocaman","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ymgme.2022.106979_bb1105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00228-022-03279-1","article-title":"Evaluation of serum levels of asprosin and other metabolic profiles in patients with idiopathic tonic-clonic generalized epilepsy on treatment with valproic acid","volume":"78","author":"Yaryari","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1110","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3389\/fphys.2018.01782","article-title":"Acute anaerobic exercise affects the secretion of Asprosin, Irisin, and other cytokines - a comparison between sexes","volume":"9","author":"Wiecek","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jfo.2021.09.011","article-title":"Laboratory evidence on a direct correlation between acute central serous chorioretinopathy and tenascin C, metalloprotein 1, BAX, BCL2, subfatin and asprosin","volume":"45","author":"Celik","year":"2022","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000500523","article-title":"decreased circulating levels of asprosin in obese children","volume":"91","author":"Long","year":"2019","journal-title":"Hormone Res. Paediatr."},{"key":"10.1016\/j.ymgme.2022.106979_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155477","article-title":"Asprosin serum levels and glucose homeostasis in children with obesity","volume":"142","author":"Corica","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.ymgme.2022.106979_bb1130","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194022","article-title":"Apelin-13 and asprosin in adolescents with anorexia nervosa and their association with psychometric and metabolic variables","volume":"14","author":"Jowik","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2022.106979_bb1135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.33549\/physiolres.934547","article-title":"Plasma asprosin, CCDC80 and ANGPTL4 levels are associated with metabolic and cardiovascular risk in patients with inflammatory bowel disease","volume":"70","author":"Wang","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ymgme.2022.106979_bb1140","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050666","article-title":"Aerobic exercise training decreases hepatic asprosin in diabetic rats","volume":"8","author":"Ko","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb1145","doi-asserted-by":"crossref","first-page":"100111","DOI":"10.1016\/j.obmed.2019.100111","article-title":"Effect of swimming training on levels of asprosin, lipid profile, glucose and insulin resistance in rats with metabolic syndrome","volume":"15","author":"Nakhaei","year":"2019","journal-title":"Obes. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb1150","first-page":"383","article-title":"Aerobic interval training improves irisin and chemerin levels of both liver and visceral adipose tissues and circulating asprosin in rats with metabolic syndrome","volume":"108","author":"Ahmadabadi","year":"2021","journal-title":"Physiol. Int."},{"key":"10.1016\/j.ymgme.2022.106979_bb1155","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.726783","article-title":"Nordic walking at maximal fat oxidation intensity decreases circulating asprosin and visceral obesity in women with metabolic disorders","volume":"12","author":"Kantorowicz","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1160","article-title":"Decrease in serum asprosin levels following six weeks of spinning and stationary cycling training in overweight women Horm Mol biol","author":"Nakhaei","year":"2022","journal-title":"Clin. Investig."},{"key":"10.1016\/j.ymgme.2022.106979_bb1165","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8855996","article-title":"Serum levels of asprosin, a novel adipokine, are significantly lowered in patients with acromegaly","volume":"2020","author":"Ke","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1170","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091428","article-title":"Decreased blood asprosin in hyperglycemic menopausal women as a result of whole-body cryotherapy regardless of metabolic syndrome","volume":"8","author":"Wiecek","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb1175","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/oby.23471","article-title":"Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy","volume":"30","author":"Cantay","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ymgme.2022.106979_bb1180","article-title":"Evaluation of serum and salivary subfatin and asprosin hormone levels in patients with nonalcoholic steatohepatisis","volume":"70","author":"Cosar","year":"2020","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.ymgme.2022.106979_bb1185","first-page":"37","article-title":"The effect of thyroid dysfunction and treatment on adropin, asprosin and preptin levels in rats","volume":"42","author":"Mogulkoc","year":"2020","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.106979_bb1190","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3892\/ol.2021.12911","article-title":"A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer","volume":"22","author":"Kerslake","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ymgme.2022.106979_bb1195","first-page":"1","article-title":"Use of asprosin and subfatin for differential diagnosis of serous ovarian tumors","author":"Mirzaoglu","year":"2022","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.ymgme.2022.106979_bb1200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41366-021-00972-6","article-title":"CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study","volume":"46","author":"Gkouskou","year":"2022","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ymgme.2022.106979_bb1205","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202100470","article-title":"Sex-specific effects of maternal and post-weaning high-fat diet on adipose tissue Remodeling and Asprosin expression in mice offspring","volume":"66","author":"Yang","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ymgme.2022.106979_bb1210","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-021-02197-w","article-title":"Asprosin, a novel therapeutic candidate for painful neuropathy: an experimental study in mice Naunyn Schmiedebergs","author":"Ozcan","year":"2022","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1215","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2021.210423","article-title":"Asprosin and oxidative stress level in COVID-19 patients","volume":"68","author":"Seyhanli","year":"2022","journal-title":"Clin. Lab."},{"key":"10.1016\/j.ymgme.2022.106979_bb1220","first-page":"179","article-title":"Changes in the level of asprosin as a novel adipocytokine after different types of resistance training","volume":"11","author":"Jahangiri","year":"2021","journal-title":"J. Chem. Health Risks"},{"key":"10.1016\/j.ymgme.2022.106979_bb1225","first-page":"2683","article-title":"Effect of regular exercise on the levels of subfatin and asprosin: a trial with different types of exercise","volume":"26","author":"Akbulut","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb1230","article-title":"Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women","author":"Leonard","year":"2020","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1235","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/s41598-019-42061-9","article-title":"The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients","volume":"9","author":"Chang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2022.106979_bb1240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clnesp.2021.11.013","article-title":"Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial","volume":"48","author":"Shemirani","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.ymgme.2022.106979_bb1245","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11082268","article-title":"Serum asprosin concentrations in children with prader-willi syndrome: correlations with metabolic parameters","volume":"11","author":"Alsaif","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2022.106979_bb1250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13098-022-00844-7","article-title":"Association of cord blood asprosin concentration with atherogenic lipid profile and anthropometric indices","volume":"14","author":"Hussein","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ymgme.2022.106979_bb1255","doi-asserted-by":"crossref","first-page":"116554","DOI":"10.1016\/j.lfs.2019.116554","article-title":"Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1\/2-SOD2 pathway","volume":"231","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb1260","article-title":"Asprosin exacerbates endothelium inflammation induced by hyperlipidemia through activating IKKbeta-NF-kappaBp65 pathway","author":"Huang","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.ymgme.2022.106979_bb1265","doi-asserted-by":"crossref","first-page":"111451","DOI":"10.1016\/j.mce.2021.111451","article-title":"Intracerebroventricular asprosin administration strongly stimulates hypothalamic-pituitary-testicular axis in rats","volume":"538","author":"Keskin","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1270","article-title":"Asprosin in the paraventricular nucleus induces sympathetic activation and Pressor responses via cAMP-dependent ROS production","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2022.106979_bb1275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j..2004.00186.x","article-title":"An integrated approach to management of Marfan syndrome caused by an FBN1 exon 18 mutation in an Australian Aboriginal family","volume":"65","author":"Summers","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb1280","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/bonekey.2013.190","article-title":"Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome","volume":"2","author":"McInerney-Leo","year":"2013","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.ymgme.2022.106979_bb1285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/jhg.2014.73","article-title":"Three novel mutations of the FBN1 gene in Chinese children with acromelic dysplasia","volume":"59","author":"Wang","year":"2014","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb1290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/jpem-2016-0258","article-title":"Three cases of Japanese acromicric\/geleophysic dysplasia with FBN1 mutations: a comparison of clinical and radiological features","volume":"30","author":"Hasegawa","year":"2017","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb1295","first-page":"8212417","article-title":"The clinical cases of Geleophysic dysplasia: one gene, different phenotypes","volume":"2018","author":"Globa","year":"2018","journal-title":"Case Rep. Endocrinol."},{"key":"10.1016\/j.ymgme.2022.106979_bb1300","article-title":"Case report: biochemical and clinical phenotypes caused by cysteine substitutions in the epidermal growth factor-like domains of fibrillin-1","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb1305","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejmg.2010.05.002","article-title":"De novo 15q21.1q21.2 deletion identified through FBN1 MLPA and refined by 244K array-CGH in a female teenager with incomplete Marfan syndrome","volume":"53","author":"Faivre","year":"2010","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb1310","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/ajmg.a.32339","article-title":"Craniosynostosis in a patient with a de novo 15q15-q22 deletion","volume":"146A","author":"Hiraki","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2022.106979_bb1315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0030-1247510","article-title":"Neonatal Marfan syndrome: unusually large deletion of exons 24\u201326 of FBN1 associated with poor prognosis","volume":"222","author":"Apitz","year":"2010","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.ymgme.2022.106979_bb1320","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/jhg.2017.32","article-title":"Intragenic multi-exon deletion in the FBN1 gene in a child with mildly dilated aortic sinus: a retrotransposal event","volume":"62","author":"Brett","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb1325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12041-012-0165-3","article-title":"Novel de novo nonsense mutation of FBN1 gene in a patient with Marfan syndrome","volume":"91","author":"Song","year":"2012","journal-title":"J. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb1330","doi-asserted-by":"crossref","DOI":"10.3390\/genes10060442","article-title":"Characterization of two novel intronic variants affecting splicing in FBN1-related disorders","volume":"10","author":"Fusco","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymgme.2022.106979_bb1335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/03008207.2010.500430","article-title":"Osteosarcoma in a Marfan patient with a novel premature termination codon in the FBN1 gene","volume":"52","author":"Roopnariane","year":"2011","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.ymgme.2022.106979_bb1340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ymgme.2013.12.006","article-title":"Transcriptional profiling of the human fibrillin\/LTBP gene family, key regulators of mesenchymal cell functions","volume":"112","author":"Davis","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.106979_bb1345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.12.1.11","article-title":"Human interferon: mass production in a newly established cell line, MG-63","volume":"12","author":"Billiau","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgme.2022.106979_bb1350","first-page":"3743","article-title":"Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts","volume":"24","author":"Pautke","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ymgme.2022.106979_bb1355","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ejhg.2010.91","article-title":"Co-expression of FBN1 with mesenchyme-specific genes in mouse cell lines: implications for phenotypic variability in Marfan syndrome","volume":"18","author":"Summers","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.106979_bb1360","series-title":"Human Tumor Cells In Vitro","first-page":"115","article-title":"New human cell lines","author":"Fogh","year":"1975"},{"key":"10.1016\/j.ymgme.2022.106979_bb1365","first-page":"415","article-title":"Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2)","volume":"16","author":"McQuillan","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2022.106979_bb1370","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1172\/JCI117595","article-title":"Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes","volume":"94","author":"Goldring","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.106979_bb1375","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/joca.1999.0277","article-title":"Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for alpha1beta1 and alpha2beta1 integrins in mediating chondrocyte adhesion to types II and VI collagen","volume":"8","author":"Loeser","year":"2000","journal-title":"Osteoarthr. Cartil."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222004577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222004577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:55:23Z","timestamp":1761090923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222004577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":275,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1096719222004577"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.106979","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrillin-1 and asprosin, novel players in metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.106979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106979"}}